“6r” is an intelligent AI detection solution for a smarter future where we turn data into decisions from self directed machine learning robots.
Delivers by complete robotic automation and eliminates many expenses.
Validates AI data with high accuracy. Just turn it on and it does the rest through automation. Used in residences, work areas, farming, greenhouses, medical settings and meat packing facilities to name a few.
Recognizes matter in air, water and on surfaces using automated drones and robots that detect all types of matter including bacteria, viruses, fungus, allergens, toxins, pathogens and microbes, contaminates, and pollutants. Scaled up to a more robust version, 6r can also detect germs and biological agents and sequester them safely. In medical settings, human bodily fluids and tissue samples from humans as well as parasites in stool samples can be detected using AI.
Provides honest results with no political or financial persuasions. A pathogen is a pathogen, no outside influences to alter what was detected.
Offers ongoing respect for the environment, living beings and our stakeholders.
Forms new ways to conduct business with no human effort and or intervention. 6r AI Agents will automate most of the company operations after funding levels reach milestones.
6r is a cutting-edge innovated AI solution promoting an automated robotic system for detecting toxins. Our superior technology is based on drones, robots, and mobile water vehicles led by self-directed algorithms that can break apart matter in all environments with continual detection abilities. Our main goal is to provide industries with AI technology to streamline their operations with sound toxic detection solutions and to deliver our stakeholders with beneficial results.
6r offers complete automated applications that can be deployed in airports, cruise lines, dairy farms, most indoor and outdoor environments, greenhouses, food and meat packaging and many other applications where toxins need to be detected. Our 6r solution is both a static and mobile application that detects matter such as abnormal matter (toxic bacteria and contaminates) in any environment. Revenues should be generated from both the AI detection applications as well as licensing matter database to third parties.
Our 6r applications will move to the medical industry with a larger impact. For example, new medical autonomous robotic surgical procedures have been developed and filed with USPTO on February 6th, 2026. We believe self directed medical applications are in the future and plan on launching the automated medical procedures application after revenues are generated from database and detection revenues.
Pictures and videos are from a detection entity formed for research and development. “De3” assets have been transferred to DeTection Inc. and are included in this website.
On February 6, 2026, DeTection Inc. filed patent applications with the United States Patent and Trademark Office "USPTO" and the World Intellectual Patent Organization "WIPO" for Self Directed Robotic Medical Procedures.
AI machines will be trained in the same manner as doctors with manual labor or self-training. AI application training and regulatory approvals will vary in durations. Regulatory approvals durations outside of the United States will be shorter. Investors in DeTection Inc. will also own the IP in the autonomous medical procedures. Click on Automated Medical Apps for more information.
More than 3 states can be used with 6r detection- coming in 2030.
Self learning algorithms are used with the 6r.
Building a database with matter detection.
